Selected research
Industry Research
Methotrexate Injection Industry Research Report 2026
Market perspective
The global Methotrexate Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Methotrexate Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Methotrexate Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Methotrexate Injection include Accord, Get Well Pharmaceutical, Hikma, Fresenius Kabi, Guangdong Lingnan Pharma, Hengrui Medicine, Pfizer, Mylan and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Methotrexate Injection market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Methotrexate Injection Market by Company
Accord
Get Well Pharmaceutical
Hikma
Fresenius Kabi
Guangdong Lingnan Pharma
Hengrui Medicine
Pfizer
Mylan
Qilu Pharmaceutical
Shanxi Pude Pharma
Sichuan Huiyu Pharma
Teva
Youcare Pharmaceutical Group
Methotrexate Injection Segment by Type
Preservative-Free
With Preservative
Methotrexate Injection Segment by Application
Specialty Clinic
Hospital
Recovry Center
Methotrexate Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Methotrexate Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Methotrexate Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Methotrexate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Preservative-Free
- With Preservative
Applications
- Specialty Clinic
- Hospital
- Recovry Center
Companies covered
- Accord
- Get Well Pharmaceutical
- Hikma
- Fresenius Kabi
- Guangdong Lingnan Pharma
- Hengrui Medicine
- Pfizer
- Mylan
- Qilu Pharmaceutical
- Shanxi Pude Pharma
- Sichuan Huiyu Pharma
- Teva
- Youcare Pharmaceutical Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Methotrexate Injection Market Size (2021-2032)
- 2.2.2 Global Methotrexate Injection Sales (2021-2032)
- 2.2.3 Global Methotrexate Injection Market Average Price (2021-2032)
- 2.3 Methotrexate Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Preservative-Free
- 2.3.3 With Preservative
- 2.4 Methotrexate Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Specialty Clinic
- 2.4.3 Hospital
- 2.4.4 Recovry Center
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Methotrexate Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Methotrexate Injection Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Methotrexate Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Methotrexate Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Methotrexate Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Methotrexate Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Methotrexate Injection, Product Type & Application
- 3.8 Global Manufacturers of Methotrexate Injection, Established Date
- 3.9 Global Methotrexate Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Accord
- 4.1.1 Accord Company Information
- 4.1.2 Accord Business Overview
- 4.1.3 Accord Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Accord Methotrexate Injection Product Portfolio
- 4.1.5 Accord Recent Developments
- 4.2 Get Well Pharmaceutical
- 4.2.1 Get Well Pharmaceutical Company Information
- 4.2.2 Get Well Pharmaceutical Business Overview
- 4.2.3 Get Well Pharmaceutical Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Get Well Pharmaceutical Methotrexate Injection Product Portfolio
- 4.2.5 Get Well Pharmaceutical Recent Developments
- 4.3 Hikma
- 4.3.1 Hikma Company Information
- 4.3.2 Hikma Business Overview
- 4.3.3 Hikma Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hikma Methotrexate Injection Product Portfolio
- 4.3.5 Hikma Recent Developments
- 4.4 Fresenius Kabi
- 4.4.1 Fresenius Kabi Company Information
- 4.4.2 Fresenius Kabi Business Overview
- 4.4.3 Fresenius Kabi Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Fresenius Kabi Methotrexate Injection Product Portfolio
- 4.4.5 Fresenius Kabi Recent Developments
- 4.5 Guangdong Lingnan Pharma
- 4.5.1 Guangdong Lingnan Pharma Company Information
- 4.5.2 Guangdong Lingnan Pharma Business Overview
- 4.5.3 Guangdong Lingnan Pharma Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Guangdong Lingnan Pharma Methotrexate Injection Product Portfolio
- 4.5.5 Guangdong Lingnan Pharma Recent Developments
- 4.6 Hengrui Medicine
- 4.6.1 Hengrui Medicine Company Information
- 4.6.2 Hengrui Medicine Business Overview
- 4.6.3 Hengrui Medicine Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hengrui Medicine Methotrexate Injection Product Portfolio
- 4.6.5 Hengrui Medicine Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Methotrexate Injection Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Mylan
- 4.8.1 Mylan Company Information
- 4.8.2 Mylan Business Overview
- 4.8.3 Mylan Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mylan Methotrexate Injection Product Portfolio
- 4.8.5 Mylan Recent Developments
- 4.9 Qilu Pharmaceutical
- 4.9.1 Qilu Pharmaceutical Company Information
- 4.9.2 Qilu Pharmaceutical Business Overview
- 4.9.3 Qilu Pharmaceutical Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Qilu Pharmaceutical Methotrexate Injection Product Portfolio
- 4.9.5 Qilu Pharmaceutical Recent Developments
- 4.10 Shanxi Pude Pharma
- 4.10.1 Shanxi Pude Pharma Company Information
- 4.10.2 Shanxi Pude Pharma Business Overview
- 4.10.3 Shanxi Pude Pharma Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shanxi Pude Pharma Methotrexate Injection Product Portfolio
- 4.10.5 Shanxi Pude Pharma Recent Developments
- 4.11 Sichuan Huiyu Pharma
- 4.11.1 Sichuan Huiyu Pharma Company Information
- 4.11.2 Sichuan Huiyu Pharma Business Overview
- 4.11.3 Sichuan Huiyu Pharma Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sichuan Huiyu Pharma Methotrexate Injection Product Portfolio
- 4.11.5 Sichuan Huiyu Pharma Recent Developments
- 4.12 Teva
- 4.12.1 Teva Company Information
- 4.12.2 Teva Business Overview
- 4.12.3 Teva Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Teva Methotrexate Injection Product Portfolio
- 4.12.5 Teva Recent Developments
- 4.13 Youcare Pharmaceutical Group
- 4.13.1 Youcare Pharmaceutical Group Company Information
- 4.13.2 Youcare Pharmaceutical Group Business Overview
- 4.13.3 Youcare Pharmaceutical Group Methotrexate Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Youcare Pharmaceutical Group Methotrexate Injection Product Portfolio
- 4.13.5 Youcare Pharmaceutical Group Recent Developments
5 Global Methotrexate Injection Market Scenario by Region
- 5.1 Global Methotrexate Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Methotrexate Injection Sales by Region: 2021-2032
- 5.2.1 Global Methotrexate Injection Sales by Region: 2021-2026
- 5.2.2 Global Methotrexate Injection Sales by Region: 2027-2032
- 5.3 Global Methotrexate Injection Revenue by Region: 2021-2032
- 5.3.1 Global Methotrexate Injection Revenue by Region: 2021-2026
- 5.3.2 Global Methotrexate Injection Revenue by Region: 2027-2032
- 5.4 North America Methotrexate Injection Market Facts & Figures by Country
- 5.4.1 North America Methotrexate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Methotrexate Injection Sales by Country (2021-2032)
- 5.4.3 North America Methotrexate Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Methotrexate Injection Market Facts & Figures by Country
- 5.5.1 Europe Methotrexate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Methotrexate Injection Sales by Country (2021-2032)
- 5.5.3 Europe Methotrexate Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Methotrexate Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Methotrexate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Methotrexate Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Methotrexate Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Methotrexate Injection Market Facts & Figures by Country
- 5.7.1 South America Methotrexate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Methotrexate Injection Sales by Country (2021-2032)
- 5.7.3 South America Methotrexate Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Methotrexate Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Methotrexate Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Methotrexate Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Methotrexate Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Methotrexate Injection Sales by Type (2021-2032)
- 6.1.1 Global Methotrexate Injection Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Methotrexate Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Methotrexate Injection Revenue by Type (2021-2032)
- 6.2.1 Global Methotrexate Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Methotrexate Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Methotrexate Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Methotrexate Injection Sales by Application (2021-2032)
- 7.1.1 Global Methotrexate Injection Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Methotrexate Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Methotrexate Injection Revenue by Application (2021-2032)
- 7.2.1 Global Methotrexate Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Methotrexate Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Methotrexate Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Methotrexate Injection Value Chain Analysis
- 8.1.1 Methotrexate Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Methotrexate Injection Production Mode & Process
- 8.2 Methotrexate Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Methotrexate Injection Distributors
- 8.2.3 Methotrexate Injection Customers
9 Global Methotrexate Injection Analyzing Market Dynamics
- 9.1 Methotrexate Injection Industry Trends
- 9.2 Methotrexate Injection Industry Drivers
- 9.3 Methotrexate Injection Industry Opportunities and Challenges
- 9.4 Methotrexate Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst